Bioprocessing
Upstream, downstream, scale-up and biomanufacturing.
Latest Bioprocessing news
Numerical analysis of shear rate in a rocking bioreactor and its impact on HL-60 lymphocytes
Read at Bioengineer.org →Currier Evolves into Full-Service CDMO Under Alentra Brand
Read at Medical Product Outsourcing →Axio BioPharma and Elucidata Partner to Connect R&D Data with Biomanufacturing Workflows
Read at EIN News →CSL USA/Sacco System expands U.S. CDMO capabilities for microbiome innovation
Read at Nutraceutical Business Review →Erlenmeyer Flasks Market To 2035: Single-Use Bioprocessing Demand Supports Expansion - News and Statistics
Read at IndexBox →Vantage Nutrition redefines the nutraceutical CDMO category through strategic advisory and advanced delivery technologies.
Read at Asia Food Journal →From the knowledge base
ASHG: Long-Read Genomics Meets Clinical Data in PacBio, Verily Health AI Deal
A multi-year collaboration will connect PacBio's HiFi sequencing with Verily Pre, combining long-read genomic and clinical data for biomedical research and AI model development.
5 iced coffees we're bringing to a job interview
A viral post sparked debate around the professionalism of iced coffee. Explore the gallery for our five natural iced coffee picks sure to impress.
It will take more than data to improve traceability in the cotton supply chain
New research supported by Cotton Diaries explores the idea of "relational traceability" and making farmers a key source of intel.
Former MIT professor David Sabatini awarded $6M in defamation case
A Massachusetts jury awarded $6 million in damages to prominent biologist David Sabatini, years after sexual harassment allegations led to his ouster from MIT. Roughly five years ago, Sabatini brought the
How this plastic-free personal care brand tackles men's reproductive health
Learn about Old Salt Grooming's plastic-free product line paired with broader messaging around men's reproductive health and the environmental cost of personal care.
Antheia gets $80M conditional DOD loan to onshore to the US
Biosynthesis manufacturer Antheia has won a conditional loan of $80 million from the US Department of Defense to help boost the domestic production of generic drugs. "Over time, we aim to manufacture Antheia's full pipeline ...